CHEMED CORP (CHE) Fundamental Analysis & Valuation
NYSE:CHE • US16359R1032
Current stock price
377.99 USD
-6.84 (-1.78%)
At close:
377.99 USD
0 (0%)
After Hours:
This CHE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CHE Profitability Analysis
1.1 Basic Checks
- In the past year CHE was profitable.
- In the past year CHE had a positive cash flow from operations.
- In the past 5 years CHE has always been profitable.
- CHE had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of CHE (17.24%) is better than 100.00% of its industry peers.
- Looking at the Return On Equity, with a value of 27.08%, CHE belongs to the top of the industry, outperforming 92.08% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 21.08%, CHE belongs to the top of the industry, outperforming 95.05% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for CHE is significantly above the industry average of 8.94%.
- The 3 year average ROIC (21.04%) for CHE is below the current ROIC(21.08%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.24% | ||
| ROE | 27.08% | ||
| ROIC | 21.08% |
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
1.3 Margins
- CHE has a Profit Margin of 10.48%. This is amongst the best in the industry. CHE outperforms 96.04% of its industry peers.
- In the last couple of years the Profit Margin of CHE has declined.
- The Operating Margin of CHE (14.01%) is better than 86.14% of its industry peers.
- CHE's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 32.54%, CHE is in the better half of the industry, outperforming 63.37% of the companies in the same industry.
- In the last couple of years the Gross Margin of CHE has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.01% | ||
| PM (TTM) | 10.48% | ||
| GM | 32.54% |
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
2. CHE Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CHE is creating value.
- The number of shares outstanding for CHE has been reduced compared to 1 year ago.
- Compared to 5 years ago, CHE has less shares outstanding
- The debt/assets ratio for CHE is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 10.80 indicates that CHE is not in any danger for bankruptcy at the moment.
- CHE has a better Altman-Z score (10.80) than 95.05% of its industry peers.
- The Debt to FCF ratio of CHE is 0.03, which is an excellent value as it means it would take CHE, only 0.03 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 0.03, CHE belongs to the best of the industry, outperforming 93.07% of the companies in the same industry.
- A Debt/Equity ratio of 0.01 indicates that CHE is not too dependend on debt financing.
- CHE's Debt to Equity ratio of 0.01 is amongst the best of the industry. CHE outperforms 84.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.03 | ||
| Altman-Z | 10.8 |
ROIC/WACC2.33
WACC9.04%
2.3 Liquidity
- A Current Ratio of 1.05 indicates that CHE should not have too much problems paying its short term obligations.
- Looking at the Current ratio, with a value of 1.05, CHE is doing worse than 64.36% of the companies in the same industry.
- A Quick Ratio of 1.03 indicates that CHE should not have too much problems paying its short term obligations.
- The Quick ratio of CHE (1.03) is worse than 61.39% of its industry peers.
- The current and quick ratio evaluation for CHE is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.03 |
3. CHE Growth Analysis
3.1 Past
- CHE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.70%.
- Measured over the past 5 years, CHE shows a small growth in Earnings Per Share. The EPS has been growing by 3.61% on average per year.
- CHE shows a small growth in Revenue. In the last year, the Revenue has grown by 4.06%.
- Measured over the past years, CHE shows a small growth in Revenue. The Revenue has been growing by 4.00% on average per year.
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
Revenue 1Y (TTM)4.06%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%-0.1%
3.2 Future
- The Earnings Per Share is expected to grow by 10.57% on average over the next years. This is quite good.
- CHE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.60% yearly.
EPS Next Y12.32%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue Next Year4.74%
Revenue Next 2Y5.44%
Revenue Next 3Y5.6%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. CHE Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 17.51, the valuation of CHE can be described as rather expensive.
- 72.28% of the companies in the same industry are more expensive than CHE, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of CHE to the average of the S&P500 Index (25.23), we can say CHE is valued slightly cheaper.
- A Price/Forward Earnings ratio of 15.59 indicates a correct valuation of CHE.
- Based on the Price/Forward Earnings ratio, CHE is valued a bit cheaper than 73.27% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 23.28, CHE is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.51 | ||
| Fwd PE | 15.59 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, CHE is valued a bit cheaper than 60.40% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, CHE is valued a bit cheaper than the industry average as 69.31% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.99 | ||
| EV/EBITDA | 12.46 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of CHE may justify a higher PE ratio.
PEG (NY)1.42
PEG (5Y)4.85
EPS Next 2Y12.04%
EPS Next 3Y10.57%
5. CHE Dividend Analysis
5.1 Amount
- CHE has a yearly dividend return of 0.62%, which is pretty low.
- CHE's Dividend Yield is rather good when compared to the industry average which is at 0.50. CHE pays more dividend than 82.18% of the companies in the same industry.
- With a Dividend Yield of 0.62, CHE pays less dividend than the S&P500 average, which is at 1.91.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.62% |
5.2 History
- The dividend of CHE is nicely growing with an annual growth rate of 11.06%!
- CHE has paid a dividend for at least 10 years, which is a reliable track record.
- CHE has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.06%
Div Incr Years16
Div Non Decr Years21
5.3 Sustainability
- 11.95% of the earnings are spent on dividend by CHE. This is a low number and sustainable payout ratio.
- CHE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP11.95%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
CHE Fundamentals: All Metrics, Ratios and Statistics
377.99
-6.84 (-1.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25 2026-02-25/amc
Earnings (Next)04-21 2026-04-21
Inst Owners101.6%
Inst Owner Change42.44%
Ins Owners1.54%
Ins Owner Change-1.94%
Market Cap5.20B
Revenue(TTM)2.53B
Net Income(TTM)265.24M
Analysts75
Price Target566.61 (49.9%)
Short Float %3.43%
Short Ratio2.24
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.62% |
Yearly Dividend2.24
Dividend Growth(5Y)11.06%
DP11.95%
Div Incr Years16
Div Non Decr Years21
Ex-Date02-23 2026-02-23 (0.6)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.47%
Min EPS beat(2)-10.06%
Max EPS beat(2)-2.88%
EPS beat(4)1
Avg EPS beat(4)-6.89%
Min EPS beat(4)-15.11%
Max EPS beat(4)0.5%
EPS beat(8)1
Avg EPS beat(8)-5.02%
EPS beat(12)3
Avg EPS beat(12)-3.1%
EPS beat(16)7
Avg EPS beat(16)-1.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-3.96%
Max Revenue beat(2)-1.17%
Revenue beat(4)0
Avg Revenue beat(4)-1.96%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)-0.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.64%
Revenue beat(12)2
Avg Revenue beat(12)-1.3%
Revenue beat(16)2
Avg Revenue beat(16)-1.4%
PT rev (1m)0%
PT rev (3m)-3.27%
EPS NQ rev (1m)-8.48%
EPS NQ rev (3m)-8.48%
EPS NY rev (1m)-5.51%
EPS NY rev (3m)-5.76%
Revenue NQ rev (1m)-2.43%
Revenue NQ rev (3m)-2.43%
Revenue NY rev (1m)-1.24%
Revenue NY rev (3m)-1.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.51 | ||
| Fwd PE | 15.59 | ||
| P/S | 2.06 | ||
| P/FCF | 15.99 | ||
| P/OCF | 13.41 | ||
| P/B | 5.31 | ||
| P/tB | 22.67 | ||
| EV/EBITDA | 12.46 |
EPS(TTM)21.59
EY5.71%
EPS(NY)24.25
Fwd EY6.42%
FCF(TTM)23.64
FCFY6.25%
OCF(TTM)28.2
OCFY7.46%
SpS183.73
BVpS71.13
TBVpS16.68
PEG (NY)1.42
PEG (5Y)4.85
Graham Number185.88
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.24% | ||
| ROE | 27.08% | ||
| ROCE | 28.33% | ||
| ROIC | 21.08% | ||
| ROICexc | 22.41% | ||
| ROICexgc | 60.78% | ||
| OM | 14.01% | ||
| PM (TTM) | 10.48% | ||
| GM | 32.54% | ||
| FCFM | 12.86% |
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
ROICexc(3y)24.14%
ROICexc(5y)24.65%
ROICexgc(3y)64.18%
ROICexgc(5y)68.12%
ROCE(3y)28.21%
ROCE(5y)29.9%
ROICexgc growth 3Y-2.67%
ROICexgc growth 5Y-7.4%
ROICexc growth 3Y-2.26%
ROICexc growth 5Y-2.45%
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
F-Score6
Asset Turnover1.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.03 | ||
| Debt/EBITDA | 0.03 | ||
| Cap/Depr | 96.84% | ||
| Cap/Sales | 2.48% | ||
| Interest Coverage | 263.51 | ||
| Cash Conversion | 92.61% | ||
| Profit Quality | 122.71% | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 10.8 |
F-Score6
WACC9.04%
ROIC/WACC2.33
Cap/Depr(3y)89.6%
Cap/Depr(5y)92.99%
Cap/Sales(3y)2.34%
Cap/Sales(5y)2.49%
Profit Quality(3y)114.97%
Profit Quality(5y)107.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
EPS Next Y12.32%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue 1Y (TTM)4.06%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%-0.1%
Revenue Next Year4.74%
Revenue Next 2Y5.44%
Revenue Next 3Y5.6%
Revenue Next 5YN/A
EBIT growth 1Y-12.87%
EBIT growth 3Y1.18%
EBIT growth 5Y1.52%
EBIT Next Year25.84%
EBIT Next 3Y13.68%
EBIT Next 5YN/A
FCF growth 1Y-11.55%
FCF growth 3Y8.82%
FCF growth 5Y-5.44%
OCF growth 1Y-7%
OCF growth 3Y7.8%
OCF growth 5Y-4.52%
CHEMED CORP / CHE Fundamental Analysis FAQ
What is the fundamental rating for CHE stock?
ChartMill assigns a fundamental rating of 7 / 10 to CHE.
What is the valuation status of CHEMED CORP (CHE) stock?
ChartMill assigns a valuation rating of 5 / 10 to CHEMED CORP (CHE). This can be considered as Fairly Valued.
Can you provide the profitability details for CHEMED CORP?
CHEMED CORP (CHE) has a profitability rating of 8 / 10.
Can you provide the financial health for CHE stock?
The financial health rating of CHEMED CORP (CHE) is 8 / 10.
What is the earnings growth outlook for CHEMED CORP?
The Earnings per Share (EPS) of CHEMED CORP (CHE) is expected to grow by 12.32% in the next year.